Prodotto aggiunto correttamente al carrello.

discount label
Mal-LYLVCGERG-OH
Visualizzare in 3D

Biosynth logo

Mal-LYLVCGERG-OH

Rif. 3D-PP48834

Dimensione non definitaPrezzo su richiesta
Consegna stimata in Stati Uniti, il Mercoledì 06 Novembre 2024

Informazioni sul prodotto

Nome:
Mal-LYLVCGERG-OH
Descrizione:

Peptide Mal-LYLVCGERG-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using Mal-LYLVCGERG-OH include the following: During the early prediabetic period in NOD mice, the pathogenic CD8+ T-cell population comprises multiple antigenic specificities TP DiLorenzo, SM Lieberman , T Takaki, S Honda - Clinical , 2002 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S1521661602952988 Peripheral proinsulin expression controls low-avidity proinsulin-reactive CD8 T cells in type 1 diabetes TC Thayer, JA Pearson, E De Leenheer , SJ Hanna - Diabetes, 2016 - Am Diabetes Assochttps://diabetesjournals.org/diabetes/article-abstract/65/11/3429/17484 Convective-heating thermal decomposition/digestion of peptides and proteins on surfaces R Zhou, F Basile - Journal of Analytical and Applied Pyrolysis, 2017 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0165237016307987 Convective-Heating Thermal Decomposition/Digestion R Zhou, F Basile - Digestion, 2014 - academia.eduhttps://www.academia.edu/download/111737285/j.jaap.2017.07.00420240223-1-9015as.pdf A Single L/D-Substitution at Q4 of the mInsA2-10 Epitope Prevents Type 1 Diabetes in Humanized NOD Mice M Zhang, Y Wang, X Li, G Meng, X Chen - Frontiers in , 2021 - frontiersin.orghttps://www.frontiersin.org/articles/10.3389/fimmu.2021.713276/full Targeted suppression of autoreactive CD8+ T-cell activation using blocking anti-CD8 antibodies M Clement , JA Pearson, S Gras , HA Van Den Berg - Scientific reports, 2016 - nature.comhttps://www.nature.com/articles/srep35332 Functional inhibition related to structure of a highly potent insulin-specific CD8 T cell clone using altered peptide ligands LG Petrich de Marquesini - European journal of , 2008 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/eji.200737762 Proteomic identification of MHC class I-associated peptidome derived from non-obese diabetic mouse thymus and pancreas L Wang, X Li, S Yang, X Chen, J Li, S Wang - Journal of , 2023 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S1874391922002706 Peptide-specific cytotoxicity of T lymphocytes against glutamic acid decarboxylase and insulin in type 1 diabetes mellitus K Kimura, T Kawamura, S Kadotani, H Inada - Diabetes research and , 2001 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0168822700002254 The development of a sub/supercritical fluid chromatography based purification method for peptides K Govender , T Naicker , S Baijnath , HG Kruger - of Pharmaceutical and , 2020 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0731708520314254 Proinsulin Expression Shapes the TCR Repertoire but Fails to Control the Development of Low-Avidity Insulin-Reactive CD8+ T Cells JA Pearson, TC Thayer, JE McLaren, K Ladell - Diabetes, 2016 - Am Diabetes Assochttps://diabetesjournals.org/diabetes/article-abstract/65/6/1679/35164 Analysis of structure and function relationships of an autoantigenic peptide of insulin bound to H-2Kd that stimulates CD8 T cells in insulin-dependent diabetes FS Wong , AK Moustakas , L Wen - Proceedings of the , 2002 - National Acad Scienceshttps://www.pnas.org/doi/abs/10.1073/pnas.072037299 Targeting proinsulin to local immune cells using an intradermal microneedle delivery system; a potential antigen-specific immunotherapy for type 1 diabetes F Arikat, SJ Hanna, RK Singh, L Vilela, FS Wong - Journal of controlled , 2020 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0168365920301218 Adoptive transfer of autoimmune diabetes using immunodeficient nonobese diabetic (NOD) mice E De Leenheer , FS Wong - Type-1 Diabetes: Methods and Protocols, 2016 - Springerhttps://link.springer.com/protocol/10.1007/7651_2015_294 MCS-18, a novel natural plant product prevents autoimmune diabetes C Seifarth, L Littmann, Y Resheq, S Rössner - Immunology , 2011 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0165247811001325 Antigen-dependent immunotherapy of non-obese diabetic mice with immature dendritic cells C Haase, L Yu, G Eisenbarth - Clinical & Experimental , 2010 - academic.oup.comhttps://academic.oup.com/cei/article-abstract/160/3/331/6428884 Presentation of Antigen by Endothelial Cells and Chemoattraction Are Required for Homing of Insulin-specific CD8+ T Cells AY Savinov , FS Wong , AC Stonebraker - The Journal of , 2003 - rupress.orghttps://rupress.org/jem/article-abstract/197/5/643/39754 Contribution of Fas to diabetes development AY Savinov , A Tcherepanov - Proceedings of the , 2003 - National Acad Scienceshttps://www.pnas.org/doi/abs/10.1073/pnas.0237359100 Progression of autoimmune diabetes driven by avidity maturation of a T-cell population A Amrani, J Verdaguer , P Serra, S Tafuro, R Tan - Nature, 2000 - nature.comhttps://www.nature.com/articles/35021081

Avviso:
I nostri prodotti sono destinati esclusivamente ad uso di laboratorio. Per qualsiasi altro utilizzo, vi preghiamo di contattarci.
Marchio:
Biosynth
Conservazione lunga:
Note:

Proprietà chimiche

MDL:
Punto di fusione:
Punto di ebollizione:
Punto di infiammabilità:
Densità:
Concentrazione:
EINECS:
Merck:
Codice SA:

Informazioni sui pericoli

Numero ONU:
EQ:
Classe:
Indicazioni di pericolo:
Consigli di prudenza:
Vietato trasportare in aereo:
Informazioni sui pericoli:
Gruppo di imballaggio:
LQ:

Richiesta tecnica su: 3D-PP48834 Mal-LYLVCGERG-OH

Si prega di utilizzare piuttosto il carrello per richiedere un preventivo o un ordine

Se si desidera richiedere un preventivo o effettuare un ordine, si prega invece di aggiungere i prodotti desiderati al carrello e poi richiedere un preventivo o un ordine dal carrello. È più veloce, più economico, e potrà beneficiare degli sconti disponibili e di altri vantaggi.

* Campi obbligatori
Benvenuto su CymitQuimica!Utilizziamo i cookie per migliorare la tua visita. Non includiamo pubblicità.

Consulta la nostra Politica sui Cookie per maggiori dettagli o regola le tue preferenze in "Configura".